---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-016073"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:00:30.613980+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Corcept shareholders reject amended 2012 incentive plan at annual meeting

## Summary
- All nine director nominees elected, with votes ranging from 70.6M to 83.9M in favor.
- Amended 2012 Incentive Award Plan not approved: 39.2M for, 44.6M against, 0.4M abstain.
- Ratification of Ernst & Young as auditor for FY2022 approved with 96.4M votes for.

## SEC filing metadata
- accession: 0001628280-22-016073
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000162828022016073/0001628280-22-016073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000162828022016073/cort-20220531.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-016073
- JSON: https://secwatch.observer/filing/0001628280-22-016073.json
- Plain text: https://secwatch.observer/filing/0001628280-22-016073.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.